Our Board of Directors

Mary Jane Dykeman is managing partner at INQ Law. In addition to data law, she is a long-standing health lawyer. Her data practice focuses on privacy, artificial intelligence (AI), cyber preparedness and response, and data strategy/governance.  In her health law practice, Mary Jane focuses on clinical and enterprise risk, privacy and information management, governance, corporate/commercial and more. She is currently interim VP Legal/Risk to the Centre for Addiction and Mental Health; and was instrumental in the development of Ontario’s health privacy legislation. Mary Jane regularly consults on large data initiatives and use of data for health research, quality purposes and advanced analytics. She is deputy chair of the Canadian Blood Services Research Ethics Board; sits on the data governance and advisory committees of T-CAIREM, the Temerty Centre for Artificial Intelligence Research and Education in Medicine at the University of Toronto; and is past chair, Alzheimer Society Toronto.

Dr. Sadikovic holds the prestigious position of London Health Sciences Research Chair in Clinical Genomics and Epigenomics and is a Professor in the Department of Pathology and Laboratory Medicine, as well as the Department of Pediatrics at Western University. He is also the Scientific and Clinical Director of the Verspeeten Clinical Genome Centre at London Health Sciences, where he spearheads both clinical and translational genomics research focused on the development of genomic and epigenomic biomarkers and diagnostic technologies for rare, complex, and oncological disorders. In his clinical capacity, Dr. Sadikovic serves as the Program Head of the Molecular Diagnostics Program, overseeing the clinical molecular diagnostics laboratories at the London Health Sciences Centre. He completed his PhD at Western University, followed by a Canadian Cancer Society Postdoctoral Fellowship at Princess Margaret and SickKids Hospitals. His clinical training includes ABMG Clinical Molecular Genetics and Clinical Cytogenetics Fellowships at Baylor College of Medicine. Dr. Sadikovic is the inventor of the EpiSign technology and a leading principal investigator in numerous national and international studies focusing on the development and application of epigenomic biomarkers in rare diseases and other medical areas.

Tammy Quigley is a senior executive at one of Canada’s largest hospitals, London Health Sciences Centre (LHSC) in London, Ontario, Canada. She successfully leads a broad portfolio including the London Health Sciences Centre Research Institute, academic alignment, patient experience, quality, patient safety, organisational risk, innovation and business development. Known for her passionate commitment to patients, she is influential in regional, provincial, and national health policy.  Her academic work includes a focus on the use of performance data to influence clinical practice in support of quality, patient-centred care.

Ting-Yim Lee, PhD is Professor of Medical Imaging, Medical Biophysics and Oncology at Western University, London, Ontario.  His research interest focuses on the use of imaging to study physiological and molecular processes in diseases.  His lab has pioneered a method of using x-ray dye and CT scanning to measure blood flow in various tissues including the brain, tumors, and the heart. The software implementation of the method has been licensed to GE Healthcare for the past 25 years and is distributed worldwide by them for use with their CT scanners. Expanding upon the CT blood flow measurement technique, his current research endeavors center on devising analytical methods for dynamic PET imaging with targeted probes to elucidate the molecular mechanisms underlying cancers. Additionally, he is investigating internal radiation dosimetry for radioligand therapy.